EUROPHARMEDTECH
Board
2 directors, no change since 2023Director (not named in the articles)
appointed by deed of 23-03-2023
term without a fixed end
earlier manager, until 23-03-2023
listed in the 2025 annual accounts, filed on 31-08-2026
Director (not named in the articles)
appointed by deed of 23-03-2023
term without a fixed end
earlier manager, until 23-03-2023
listed in the 2025 annual accounts, filed on 31-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 12 : Pouvoirs du gérant Conformément à l'article 257 du Code des Sociétés et sauf organisation par l'assemblée d'un collège de…”deed of 30-11-2017
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Director (not named in the articles)
BoardEarlier
Mandates as a list
-
- Manager (not named in the articles), appointed by deed of 30-11-2017, until 23-03-2023
- Director (not named in the articles), appointed by deed of 23-03-2023, still in office
-
- Director, appointed by deed of 17-04-2020, until 23-03-2023
- Director (not named in the articles), appointed by deed of 23-03-2023, still in office
Control
Founders
,
This company
EUROPHARMEDTECH
Equity -€28,814
Loss €69,941 in 2025
Capital
- Contribution
- €18,600
- Shares
- 1,000
- Contribution per share
- €18.60
- Equity per share
- -€28.81 in 2025
- Source
- deed of 23-03-2023
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 30-11-2017 (in French)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Friday of May at 18:00deed of 23-03-2023 (in French)
Shareholders
At incorporation
deed of 30-11-2017 ↗
- 999 shares (99.9%)
- 1 share (0.1%)
Capital transactions
Capital over time
- 23-03-2023 Converted to unavailable equity · €18,600
- 30-11-2017 Incorporation · €18,600 · 1,000 shares